# Spica Therapeutics

**Private**  
**Antwerp**  
**Healthcare & Life Sciences**  
[Spica Therapeutics Website](https://spicatx.com/)

**Last Round**: Grant  
**Date**: Aug 27, 2025  
**Total Funding Raised**: $12.54M  
**Momentum**: Top 50% of companies Caplight tracks

## Company Overview  
Spica Therapeutics is a biotechnology company that develops macrophage-subset targeted therapies using a proprietary functional fingerprinting platform to address oncology and fibroinflammatory diseases.

**Sector**: Healthcare & Life Sciences  
**Verticals**: Biotechnology, Drug Discovery, Precision Medicine  
**Business Model**: B2B  
**Customer Profile**: Services & Consulting  
**AI Layer**: Non-AI  
**Keywords**: biotechnology, drug discovery, macrophage therapy, oncology, precision medicine, fibroinflammatory disease, autoimmune disease, antibody development, targeted therapy, biotech startup, preclinical research, drug pipeline, therapeutics, biopharma

## Spica Therapeutics Comparables  
Compare Spica Therapeutics with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| [Macomics](/content/company/macomics/index.html) | 87% | N/A |
| [DEM BioPharma](/content/company/dem-biopharma/index.html) | 79% | N/A |
| [Resolute Science](/content/company/resolutescience/index.html) | 79% | N/A |
| Comparable company | 50% | N/A |

## Spica Therapeutics Funding Rounds  
Historical fundraising activity.

| Round | Date | Amount Raised | Valuation | Investors |
| --- | --- | --- | --- | --- |
| Grant | Aug 27, 2025 | N/A | N/A | N/A |
| Seed | Jun 4, 2025 | N/A | N/A | N/A |

## Spica Therapeutics Investors  
Notable investors and investment history.

| Investor | Rounds |
| --- | --- |
| [VLAIO](/content/investor/vlaio/index.html) | Grant |
| [Bioqube Ventures](/content/investor/bioqubeventures/index.html) | Seed |
| [PMV](/content/investor/pmv/index.html) | Seed |

## Market Signals  
Structured signals derived from secondary market and firmographic data.

- May 15, 2026: Monthly visitors increased 47% MoM.
- Aug 27, 2025: $1.2M grant received.

## Spica Therapeutics Filings  
SEC and related filings with document metadata.

| Typed | Date | Amount Offered | Amount Sold |
| --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |

## Frequently Asked Questions  
Common questions about Spica Therapeutics's valuation, stock price, and market status.

- Is Spica Therapeutics a public or private company?  
- What is the current stock price of Spica Therapeutics?  
- How much is Spica Therapeutics worth (valuation)?  
- Can I buy Spica Therapeutics stock?  
- When was Spica Therapeutics's last funding round?  
- Who are the main investors in Spica Therapeutics?  
- Will Spica Therapeutics IPO soon?  
- How can I track Spica Therapeutics secondary market activity?

## Firmographic Details  
**Headquarters**: Antwerp  
**Employee Range**: 16  
**Year Founded**: 2024  
**Last Funding**: Aug 27, 2025